Upon subgroup analysis, patients with TNBC had a higher proportion of LPBC, followed by those with HER2 enriched breast cancer, while patients with LA and LB types of breast cancer had the smallest proportion of LPBC (P < 0.001) (Fig 3A). This evidence concerns the gene ERBB2 and breast cancer.